A combination of the herbal extracts curcumin and Qing Dai can induce remission in a significant proportion of patients with active ulcerative colitis (UC), according to the results of a phase 2 ...
Learn about the potential benefits of the Mediterranean diet for managing ulcerative colitis, including lower inflammation and improved gut health, with expert tips.
Please provide your email address to receive an email when new articles are posted on . The FDA has approved Johnson & Johnson’s Tremfya, a dual acting interleukin-23 inhibitor, for the treatment of ...
The American College of Gastroenterology has released updated guidelines on the diagnosis and management of patients with mildly and moderately to severely active ulcerative colitis. Perspective from ...
The FDA expanded the indications for guselkumab (Tremfya) to include adults with moderately to severely active ulcerative colitis, Johnson & Johnson announced on Wednesday. Approval of the dual-acting ...
October 14, 2009 — Infliximab treatment is linked to lower colectomy rates in patients with moderate to severe active ulcerative colitis, according to the results of a prespecified analysis from 2 ...
NEW YORK--(BUSINESS WIRE)--Pfizer Inc. (NYSE: PFE) announced today that the U.S. Food and Drug Administration (FDA) has approved VELSIPITY™ (etrasimod), an oral, once-daily, selective ...
Patients with active ulcerative colitis may be able to reduce symptoms and achieve remission by taking a plant-based treatment combining the herbal compounds curcumin and qingdai, preliminary results ...
How Does Tremfya Work for Ulcerative Colitis? Tremfya is a monoclonal antibody that reduces inflammation. The main ingredient in Tremfya is a medicine called guselkumab. This medicine blocks a ...